Table 2.
Characteristics | No. of Patients With Local Recurrence (%) | Univariable HR (95% CI) | P |
---|---|---|---|
Age (y) | |||
<65 | 18/74 (24.3) | 1.07 (0.55–2.11) | .84 |
≥65 | 16/67 (23.9) | 1 | |
Gender | |||
Female | 3/21 (14.3) | 1 | |
Male | 31/120 (25.8) | 1.94 (0.59–6.34) | .27 |
cT‐stadium | |||
T1 | 11/61 (18.0) | 1 | |
T2 | 23/80 (28.8) | 1.77 (0.86–3.62) | .12 |
cN‐stadium | |||
N0 | 28/125 (22.4) | 1 | |
N+ | 6/16 (37.5) | 2.0 (0.83–4.85) | .12 |
Location | |||
Glottis | 22/93 (23.7) | 1 | |
Supraglottis | 12/48 (25) | 1.04 (0.52–2.11) | .90 |
pATM | |||
Low | 20/103 (19.4) | 1 | |
High | 14/38 (36.8) | 2.14 (1.08–4.24) | .03* |
pChk2 | |||
Low | 31/136 (22.8) | 1 | |
High | 3/5 (60.0) | 3.16 (0.96–10.37) | .06 |
p53 | |||
Low | 2/11 (18.2) | 1 | |
High | 14/65 (21.5) | 1.31 (0.30–5.75) | .72 |
CI = confidence interval; HR = hazard ratio; N = node; T = tumor.
Signifies statistically significant relation.